These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 27508489)
1. Evaluation of Cardiovascular Risk Factors, Haematological and Biochemical Parameters, and Serum Endocan Levels in Patients with Lichen Planus. Ozlu E; Karadag AS; Toprak AE; Uzuncakmak TK; Gerin F; Aksu F; Ozakpınar O; Akdeniz N Dermatology; 2016; 232(4):438-43. PubMed ID: 27508489 [TBL] [Abstract][Full Text] [Related]
2. Homocysteine and other cardiovascular risk factors in patients with lichen planus. Saleh N; Samir N; Megahed H; Farid E J Eur Acad Dermatol Venereol; 2014 Nov; 28(11):1507-13. PubMed ID: 24330130 [TBL] [Abstract][Full Text] [Related]
3. Serum endocan as a predictive biomarker of cardiovascular risk in erectile dysfunction patients. Elkamshoushi AAM; Hassan EM; El Abd AM; Hassan SZ; Maher AA Andrologia; 2018 Dec; 50(10):e13113. PubMed ID: 30039584 [TBL] [Abstract][Full Text] [Related]
4. The relationship between the atherosclerotic cardiovascular disease risk score used in the prediction of cardiovascular disease risk and endocan. Cakirca M; Dae SA; Zorlu M; Kiskac M; Tunc M; Karatoprak C Niger J Clin Pract; 2019 May; 22(5):713-717. PubMed ID: 31089028 [TBL] [Abstract][Full Text] [Related]
5. Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Yilmaz MI; Siriopol D; Saglam M; Kurt YG; Unal HU; Eyileten T; Gok M; Cetinkaya H; Oguz Y; Sari S; Vural A; Mititiuc I; Covic A; Kanbay M Kidney Int; 2014 Dec; 86(6):1213-20. PubMed ID: 24988065 [TBL] [Abstract][Full Text] [Related]
6. Inverse association between serum endocan levels and small LDL and HDL particles in patients with type 2 diabetes mellitus. Klisic A; Kavaric N; Vujcic S; Mihajlovic M; Zeljkovic A; Ivanisevic J; Spasojevic-Kalimanovska V; Ninic A; Kotur-Stevuljevic J; Vekic J Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8127-8135. PubMed ID: 32767341 [TBL] [Abstract][Full Text] [Related]
7. Endocan, TGF-beta, and ADMA as Risk Factors for Endothelial Dysfunction and Possible Vascular Disease in Patients with Subclinical Hypothyroidism. Arpaci D; Karakece E; Tocoglu AG; Ergenc H; Gurol G; Ciftci IH; Tamer A Ann Clin Lab Sci; 2016 Dec; 46(6):601-607. PubMed ID: 27993872 [TBL] [Abstract][Full Text] [Related]
8. The higher serum endocan levels may be a risk factor for the onset of cardiovascular disease: A meta-analysis. Zhao T; Kecheng Y; Zhao X; Hu X; Zhu J; Wang Y; Ni J Medicine (Baltimore); 2018 Dec; 97(49):e13407. PubMed ID: 30544417 [TBL] [Abstract][Full Text] [Related]
9. Endocan--the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Pawlak K; Mysliwiec M; Pawlak D Clin Biochem; 2015 Apr; 48(6):425-30. PubMed ID: 25617664 [TBL] [Abstract][Full Text] [Related]
11. Serum levels of endocan and endoglin are associated with large-artery atherosclerotic stroke. He XW; Ke SF; Bao YY; Hong WJ; Shen YG; Li C; Zhu F; Wang E; Jin XP Clin Chim Acta; 2018 Mar; 478():157-161. PubMed ID: 29287901 [TBL] [Abstract][Full Text] [Related]
12. Levels of endothelial cell-specific molecule-1 (ESM-1) in overt hypothyroidisim. Gungor A; Palabiyik SS; Bayraktutan Z; Dursun H; Gokkaya N; Bilen A; Bilen H Endocr Res; 2016 Nov; 41(4):275-280. PubMed ID: 26906498 [TBL] [Abstract][Full Text] [Related]
13. Endocan: A novel inflammatory indicator in cardiovascular disease? Balta S; Mikhailidis DP; Demirkol S; Ozturk C; Celik T; Iyisoy A Atherosclerosis; 2015 Nov; 243(1):339-43. PubMed ID: 26448266 [TBL] [Abstract][Full Text] [Related]
14. Serum endocan and preoperative systemic inflammatory markers in patients with epilepsy. Faruk Ozdemir A; Kemerdere R; Orhan B; Ozturk Emre H; Bercik Inal B; Kayhan A; Naz Yeni S; Tanriverdi T Neurochirurgie; 2020 Feb; 66(1):29-35. PubMed ID: 31634507 [TBL] [Abstract][Full Text] [Related]
15. Endocan as a predictor of increased cardiovascular risk during the menopausal transition period. Yıldız Ş; Kaya C; Gedikbaşı A; Cengiz H; Alay İ; Öztürk E; Tunca AF; Yaşar L Arch Gynecol Obstet; 2020 Jun; 301(6):1553-1560. PubMed ID: 32270331 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism. Güzel A; Duran L; Köksal N; Torun AC; Alaçam H; Ekiz BC; Murat N Blood Coagul Fibrinolysis; 2014 Apr; 25(3):272-6. PubMed ID: 24509328 [TBL] [Abstract][Full Text] [Related]
17. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis. Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955 [TBL] [Abstract][Full Text] [Related]
18. Serum endothelial cell specific molecule-1 (endocan) levels in patients with obstructive sleep apnea. Bingol Z; Kose M; Pıhtılı A; Akpınar T; Tukek T; Kıyan E Biomark Med; 2016; 10(2):177-84. PubMed ID: 26808694 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular risk factors in patients with lichen planus. Arias-Santiago S; Buendía-Eisman A; Aneiros-Fernández J; Girón-Prieto MS; Gutiérrez-Salmerón MT; Mellado VG; Naranjo-Sintes R Am J Med; 2011 Jun; 124(6):543-8. PubMed ID: 21605731 [TBL] [Abstract][Full Text] [Related]
20. Characteristics of serum endocan levels in infection. Seo K; Kitazawa T; Yoshino Y; Koga I; Ota Y PLoS One; 2015; 10(4):e0123358. PubMed ID: 25894539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]